Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Grants Breakthrough Therapy Status To Gilead's Trodelvy
GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer
Gilead Sciences GILD announced that its first-in-class Trop-2-directed antibody-drug conjugate, Trodelvy (sacituzumab govitecan-hziy), has been granted a second
Breakthrough
Therapy
designation by the FDA for a lung cancer indication. The indicated ...
Tolebrutinib for SPMS granted FDA breakthrough therapy designation
Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough therapy designation.
FDA Grants Breakthrough Therapy Status To Gilead's Trodelvy For Treatment Of Small Cell Lung Cancer
(RTTNews) - Gilead Sciences, Inc. (GILD) Tuesday said that the U.S. Food and Drug Administration or FDA has granted
Breakthrough
Therapy
Designation to Trodelvy for the treatment of adults with ...
Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA
Gilead (GILD) announced that the FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adult patients with
Gilead gets FDA breakthrough therapy status for Trodelvy
Gilead Sciences (NASDAQ:GILD) said it has received FDA Breakthrough Therapy Designation for its antibody-drug conjugate Trodelvy in the treatment of extensive-stage small cell lung cancer, or ES-SCLC.
The Mind of Griff on MSN
48m
Finding Hope: A Paralyzed Woman’s Journey with an FDA-Approved Breakthrough Treatment
With the FDA recently approving a revolutionary treatment aimed at helping those with spinal cord injuries, Schneider's ...
New Atlas
5h
"100% successful" cancer drug gets landmark FDA approval
Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...
5h
Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS
Sanofi ( (SNY) ) has issued an announcement. Sanofi announced that the FDA has granted Breakthrough Therapy designation to tolebrutinib for treating non-relapsing secondary progressive multiple ...
12d
Breakthrough gene therapy offers new hope to child with muscular dystrophy
Monroe Carell was a natural fit to offer the new therapy. Its multidisciplinary DMD Clinic, co-directed by Burnette, Soslow ...
2d
Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade)
Kura Oncology, Inc.'s partnership and promising AML treatment make it a top stock pick with significant upside potential for ...
abc7NY on MSN
1d
Breakthrough law offers cancer patients in New York relief for 'scalp-cooling therapy'
NEW YORK (WABC) -- A
breakthrough
is offering good
news
for cancer patients who lose their hair during chemotherapy. New ...
1d
Scientists Crack Cancer’s Hidden Defense With a Breakthrough Protein Discovery
Scientists have discovered a key protein that helps cancer cells avoid detection by the immune system during a type of ...
Monthly Prescribing Reference
4d
Tobevibart Plus Elebsiran Designated Breakthrough Therapy for Chronic Hepatitis Delta
The Breakthrough Therapy designation is supported by data from the randomized, open-label phase 2 SOLSTICE trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Sanofi
Gilead Sciences
Trodelvy
ES-SCLC
Feedback